NCT

A partnership involving Heidelberg University Hospital, the National Center for Tumor Diseases, and the German Cancer Research Institute is serving patients across Germany.

The tumor cell genome of 250 prostate cancer patients ages 50 and younger will be compared with gene sequences from healthy cells to uncover gene mutations that can cause and promote prostate cancer, and ultimately to create a map of all genetic modifications involving prostate cancer.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.